Proactive Investors - Run By Investors For Investors

Tilray trading halted twice after stock rallies to record at US$300 before profit-taking kicks in

Shares stage rip-roaring rally after company is allowed to ship drug for a study in the US; stock swung wildly before closing up over 40% for the session
cannabis plants
Tilray rallies strongly before trading halted.

Trading in Canadian cannabis company Tilray Inc (NASDAQ:TLRY) was halted twice on Wednesday in a wild session where the stock nearly doubled from the previous close at one point, whipsawed into negative ground later and then spiked in the last 15 minutes of business to finish higher.

Tilray stock soared to trade at a record US$300 per share before suspected sell-stop orders kicked in from players taking money off the table to knock the stock down to US$263.34, still up almost 70% on the day.

At that point, trading in the stock was halted for the first time.

READ: Tilray CEO encourages pharma and booze companies to enter the cannabis space; shares soar

The shares began trading some 10 minutes later and traded 64% up at US$257.73 about an hour before the close of business.

Some 40 miuntes before the close, trading was halted again and Tilray was last seen at US$224.68, up almost 45% for the session.  

When trading resumed again about 10 minutes later, Tilray dove to trade at US$151.40, under the previous closing price of US$154.98. The stock then spiked into the close, jumping over 40% in 15 minutes of trade.

Tilray shares ended on Wednesday at US$214.06, higher by US$59.08 or by 38.12%. The stock was down however by 14% in after hours trade to US$183.63.

READ: Cannabis short-sellers may be forced to cover soon as huge losses pile up, says S3 Partners

The rally in Tilray was inspired by news that the company had received approval to send a medical cannabis study drug to California.

S3 Partners analyst Ihor Dusaniwsky said Tilray is not yet a short squeeze, but it is getting close.

The blistering advance forced shorts to fork over larger amounts of funds to maintain their margins and positions in the market, analysts said.

Options activity in Tilray had exploded, with volume nearly quadruple the average daily trading volume of 40,000 contracts, a report by Reuters said.

The Canadian cannabis sector has been a battleground between those touting the market opportunity stemming from the legalization of cannabis in Canada and short sellers who believe the stocks in the market are grossly overvalued.

Tilray is  a cannabis producer based in Canada. 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TLRY profile View Profile

Tilray Inc Timeline

Related Articles

May 08 2019
TGOD has been busy building out its facilities in Ontario, Quebec, and Jamaica and expects to reach combined production of 219,000 kilograms of cannabis around 2021
cannabis facility
January 24 2019
The company will capitalize on the need for indoor-grown, pharmaceutical-grade cannabis
Sydney Harbour Bridge
January 23 2019
A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use